Genital Herpes
Valtrex evaluated in HIV-infected patients
Published in TB and Outbreaks Week, November 19th, 2002
After 6 months, the proportion of patients recurrence-free was 80% in those receiving Valtrex 500 mg twice daily, compared to only 38% of those receiving placebo.
"Many people who are HIV-positive also suffer from genital herpes and will be pleased to know they can suppress their genital herpes outbreaks," said Timothy Schacker, MD, associate professor of medicine, University of Minnesota. "This is important information...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- HIV/AIDS Tuberculosis
Antiretroviral therapy restores some anti-TB immune activity - Tuberculosis Diagnosis
Adenosine deaminase, interferon useful for tuberculous pericarditis diagnosis - Antibiotic Resistance
TRUST 2002 study shows levofloxacin resistance remains rare in S. pneumoniae - Infectious Disease Testing
Urine-based Legionnaires screens often miss mild cases - Influenza Therapy
Polyvalent sialic acid binding inhibitors show promise against some flu strains - Tuberculosis Therapy
Novel screen can identify mycobacterial dihydrofolate reductase blockers - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
